Henlius’ Rituximab Results Bolster RA Ambitions In China

Reports Positive Phase III Data At National Congress Of Chinese Rheumatology

 
• By David Wallace
  
China Flag Thumbs Up
Henlius is hoping to secure Chinese approval for the RA indication • Source: Alamy

More from Biosimilars

More from Products